These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21292829)

  • 1. The IGF pathway regulates ERα through a S6K1-dependent mechanism in breast cancer cells.
    Becker MA; Ibrahim YH; Cui X; Lee AV; Yee D
    Mol Endocrinol; 2011 Mar; 25(3):516-28. PubMed ID: 21292829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation.
    Yamnik RL; Digilova A; Davis DC; Brodt ZN; Murphy CJ; Holz MK
    J Biol Chem; 2009 Mar; 284(10):6361-9. PubMed ID: 19112174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptotanshinone inhibition of mammalian target of rapamycin pathway is dependent on oestrogen receptor alpha in breast cancer.
    Pan Y; Shi J; Ni W; Liu Y; Wang S; Wang X; Wei Z; Wang A; Chen W; Lu Y
    J Cell Mol Med; 2017 Sep; 21(9):2129-2139. PubMed ID: 28272775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplified in Breast Cancer Regulates Transcription and Translation in Breast Cancer Cells.
    Ochnik AM; Peterson MS; Avdulov SV; Oh AS; Bitterman PB; Yee D
    Neoplasia; 2016 Feb; 18(2):100-10. PubMed ID: 26936396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation.
    Maruani DM; Spiegel TN; Harris EN; Shachter AS; Unger HA; Herrero-González S; Holz MK
    Oncogene; 2012 Dec; 31(49):5073-80. PubMed ID: 22286763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin Receptor Substrate Suppression by the Tyrphostin NT157 Inhibits Responses to Insulin-Like Growth Factor-I and Insulin in Breast Cancer Cells.
    Yang Y; Chan JY; Temiz NA; Yee D
    Horm Cancer; 2018 Dec; 9(6):371-382. PubMed ID: 30229539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation.
    Alayev A; Salamon RS; Berger SM; Schwartz NS; Cuesta R; Snyder RB; Holz MK
    Oncogene; 2016 Jul; 35(27):3535-43. PubMed ID: 26522726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships.
    Sisci D; Morelli C; Cascio S; Lanzino M; Garofalo C; Reiss K; Garcia M; Russo A; Andò S; Surmacz E
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi81-5. PubMed ID: 17591841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo.
    Shrivastav A; Bruce M; Jaksic D; Bader T; Seekallu S; Penner C; Nugent Z; Watson P; Murphy L
    Breast Cancer Res; 2014 May; 16(3):R49. PubMed ID: 24887419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells.
    Mingo-Sion AM; Ferguson HA; Koller E; Reyland ME; Van Den Berg CL
    Breast Cancer Res Treat; 2005 Jun; 91(3):259-69. PubMed ID: 15952059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
    Surmacz E; Bartucci M
    J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
    Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
    Lee SJ; Yang EK; Kim SG
    Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3K/mTOR mediate mitogen-dependent HDAC1 phosphorylation in breast cancer: a novel regulation of estrogen receptor expression.
    Citro S; Miccolo C; Meloni L; Chiocca S
    J Mol Cell Biol; 2015 Apr; 7(2):132-42. PubMed ID: 25801958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
    Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
    J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line.
    García MA; Peña D; Alvarez L; Cocca C; Pontillo C; Bergoc R; de Pisarev DK; Randi A
    Toxicol Lett; 2010 Feb; 192(2):195-205. PubMed ID: 19879930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of S6K1 in ER-positive breast cancer.
    Holz MK
    Cell Cycle; 2012 Sep; 11(17):3159-65. PubMed ID: 22895181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.